跳至主要内容
临床试验/NCT02304913
NCT02304913招募中不适用

Hypoglossal Acupuncture for Dysgeusia in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial

Universität Duisburg-Essen6 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
75
试验地点
6
主要终点
Dysgeusia (Phantogeusia) (NRS - Numeric Rating Scale)

研究概览

简要总结

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

详细描述

Taste disorders are frequent side effects in patients undergoing chemotherapy (CTX). Dysguesia has prevalence rates of 16% to 1000% during CTX with sometimes also persistent courses. Impact of dysguesia on appetite, body weight as well as health-related quality of life was shown. Until now, evidence for adequate treatment options is limited to specific diary recommendations. Acupuncture in the treatment of side effects of chemotherapy was investigated for nausea and xerostomia, but not for dysguesia. Therefore, this randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Initial treatment with platinum-containing or taxane-based CTX (regardless of the the length of the CTX cycle)
  • Senological, gynecological or internistic tumors
  • Phantogeusia (on average ≥4 NRS)
  • Willingness to participate in the study and written informed consent

排除标准

  • Severe stomatitis
  • Dysgeusia before the CTX based on neurological diseases, diabetes, or the ingestion of drugs with taste disorders as side effects
  • Leucopenia/neutropenia
  • Intake of anticoagulants
  • Severe physical or mental comorbidity (due to which the patient is unable to participate in the study)
  • Participation in other CAM treatments within the integrative oncology care
  • Participation in other studies on the effectiveness of interventions for oral complications

研究组 & 干预措施

Hypoglossal acupuncture

Experimental

Single treatment of hypoglossal needle acupuncture during the chemotherapy administration: Treated points will be Jinjin (Golden Liquid/EX-HN12) left beside the lingual frenulum and Yuye (Jade Fluid/EX-HN13) right beside the lingual frenulum. Both points are treated in quick succession with immediate removal of the needle.

干预措施: Hypoglossal acupuncture (Other)

Sham acupuncture

Sham Comparator

Single treatment of hypoglossal sham acupuncture uring the chemotherapy administration: Treated points will be 1 to 1.5 cun (a cun is defined as the width of the patient's thumb at the knuckle) beside the verum acupuncture points Jinjin and Yuye using the dull side of the needle.

干预措施: Sham acupuncture (Other)

Dietary recommendations

Active Comparator

This group adheres to specific dietary recommendations for dysgeusia of the German Cancer Society.

干预措施: Dietary recommendations (Behavioral)

结局指标

主要结局

Dysgeusia (Phantogeusia) (NRS - Numeric Rating Scale)

时间窗: 7 days

次要结局

  • Appetite (NRS - Numeric Rating Scale)(7 days)
  • Xerostomia (NRS - Numeric Rating Scale)(7 days)
  • Impairment (NRS - Numeric Rating Scale)(7 days)
  • Adverse Events (free text)(7 days)
  • Dysgeusia (Parageusia, Hypogeusia, Hypergeusia) (NRS - Numeric Rating Scale)(7 days)
  • Stomatitis (NRS - Numeric Rating Scale)(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heidemarie Haller

Postdoctoral Research Fellow

Universität Duisburg-Essen

研究点 (6)

Loading locations...

相似试验